Among responders, the proportion of CD14+ monocytes in leukemia cell increased after ICI treatment across all defined radial neighborhoods (rate ratio [RR] range 2.5–2.7, adjusted p-values < 0.001). This evidence concerns the gene CD14 and leukemia.